Atara Biotherapeutics (ATRA) Capital Expenditures Growth (5y) (2019 - 2024)
Atara Biotherapeutics (ATRA) Capital Expenditures Growth (5y) (2019 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Atara Biotherapeutics |
134.61 Mn |
126.21 Mn |
392,000.00 |
| Date | Value |
|---|
| Dec 31, 2024 |
-55.28% |
| Jun 30, 2024 |
16.55% |
| Mar 31, 2024 |
-28.21% |
| Dec 31, 2023 |
-67.72% |
| Sep 30, 2023 |
39.71% |
| Jun 30, 2023 |
-18.12% |
| Mar 31, 2023 |
-37.26% |
| Dec 31, 2022 |
-67.40% |
| Sep 30, 2022 |
40.28% |
| Jun 30, 2022 |
-17.66% |
| Mar 31, 2022 |
41.83% |
| Dec 31, 2021 |
48.47% |
| Sep 30, 2021 |
-52.39% |
| Jun 30, 2021 |
22.47% |
| Mar 31, 2021 |
19.78% |
| Dec 31, 2020 |
-70.40% |
| Sep 30, 2020 |
152.48% |
| Mar 31, 2020 |
205.61% |
| Dec 31, 2019 |
247.32% |
| Sep 30, 2019 |
114.30% |
